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Abstract
a-Conotoxins potently inhibit isoforms of nicotinic acetylcholine receptors (nAChRs), which are essential for neuronal and
neuromuscular transmission. They are also used as neurochemical tools to study nAChR physiology and are being evaluated
as drug leads to treat various neuronal disorders. A number of experimental studies have been performed to investigate the
structure-activity relationships of conotoxin/nAChR complexes. However, the structural determinants of their binding
interactions are still ambiguous in the absence of experimental structures of conotoxin-receptor complexes. In this study,
the binding modes of a-conotoxin ImI to the a7-nAChR, currently the best-studied system experimentally, were
investigated using comparative modeling and molecular dynamics simulations. The structures of more than 30 single point
mutants of either the conotoxin or the receptor were modeled and analyzed. The models were used to explain qualitatively
the change of affinities measured experimentally, including some nAChR positions located outside the binding site.
Mutational energies were calculated using different methods that combine a conformational refinement procedure
(minimization with a distance dependent dielectric constant or explicit water, or molecular dynamics using five restraint
strategies) and a binding energy function (MM-GB/SA or MM-PB/SA). The protocol using explicit water energy minimization
and MM-GB/SA gave the best correlations with experimental binding affinities, with an R
2 value of 0.74. The van der Waals
and non-polar desolvation components were found to be the main driving force for binding of the conotoxin to the nAChR.
The electrostatic component was responsible for the selectivity of the various ImI mutants. Overall, this study provides novel
insights into the binding mechanism of a-conotoxins to nAChRs and the methodological developments reported here open
avenues for computational scanning studies of a rapidly expanding range of wild-type and chemically modified a-
conotoxins.
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Introduction
Nicotinic acetylcholine receptors (nAChRs) are a large family of
ligand-gated ion channels that mediate rapid synaptic transmission
in the central and peripheral nervous system [1,2]. nAChRs are
implicated in disorders such as Alzheimer’s diseases, schizophre-
nia, depression, hyperactivity disorders and tobacco addiction [3–
6]. All nAChRs are comprised of five homologous subunits, which
are divided into a large N-terminal extracellular ligand-binding
domain (LBD), a transmembrane domain, and an intracellular
domain [7] (Figure 1). The nAChR subtypes include hetero- or
homo-pentamers of a1-10, c, b1-4, d and/or e subunits. These
subtypes differ in their pharmacological and kinetic properties, as
well as their localization [8,9]. For example, the a7-nAChR is
widely expressed in the brain, whereas the a3b2-nAChR is mostly
expressed in the cerebellum and spinal cord [10].
Conotoxins are disulfide-rich toxins produced in the venom
gland of marine cone snails [11,12]. Each of the .500 species in
the Conus genus produces hundreds of different conotoxins [13–
15], which together form a large pool of many thousands of
bioactive peptides. Conotoxins target a diverse range of membrane
receptors and ion channels to rapidly and efficiently immobilize
prey [13]. The a-conotoxin family specifically and potently
inhibits nAChR subtypes and, consequently, these conotoxins
are useful tools in neurophysiological studies. The ability to
specifically target nAChRs has also attracted interest for the
development of drugs, and several conotoxins or derivatives are
currently in clinical trials for the treatment of pain [16,17]. The
majority of known a-conotoxins display a similar topology, as
shown in Figure 1. This topology includes four cysteines arranged
in a common sequence pattern -CCXmCXnC-, where X is any
non-cysteine residue, and n and m are the numbers of inter-
cysteine residues. Disulfide bonds connect cysteines I-III and II-IV
[18,19].
ImI is one of the shortest a-conotoxins, with a loop spacing
topology of m =4, n=3 [20] and, initially, was reported to
specifically interact with a7- and a9-nAChRs [21]. Later, the
a3b2-nAChR was also found to be blocked by ImI [22]. ImI has
been extensively studied: its structure has been determined using
NMR [23–25], and its interaction with the a7-nAChR has been
PLoS Computational Biology | www.ploscompbiol.org 1 March 2011 | Volume 7 | Issue 3 | e1002011probed by several mutational studies [26–31]. In the absence of a
crystallographic structure of any nAChR, several early structural
models of the binding of ImI to the LBD of a7-nAChR were
generated [22,32], but they are now superseded because better
templates, additional experimental data and improved modeling
methods are available [33–35].
In this study, an improved model of the interaction of a7-
nAChR with wild-type ImI has been developed and the structural
and energetic impact of more than 30 mutations of ImI and of
selected positions of the receptor were investigated. We describe
for the first time a model able to explain the majority of mutation
studies. Optimal methods to predict relative mutational energies
were investigated, and an approach that used energy minimization
produced excellent correlations with experimental values, produc-
ing R
2 values of 0.74. Finally, an energy decomposition of the
mutational energies was done and showed that different terms of
the energy function played distinct roles. Although we focus here
on conotoxin ImI, experimental mutational studies have been
carried out on a range of other conotoxins, in a first step toward
their development as drugs [30,31,36]. In silico mutational studies
such as those described here could dramatically accelerate the
development of conotoxin-based drugs and also help identify wild-
type toxins with interesting pharmacological activity among the
thousands of conotoxins that are predicted to exist.
Results/Discussion
In the first step of this study a model of the complex between
ImI and the human a7-nAChR LBD was generated. The
crystallographic structures of ImI bound to an Aplysia californica
acetylcholine binding protein (AChBP), which is distantly related
to nAChRs, (PDB ID: 2c9t) [34] and of bungarotoxin bound to
the LBD of an isolated subunit a1 (PDB ID: 2qc1) [35] were used
to build the initial model, using comparative modeling. Another
crystallographic structure of ImI bound to AChBP (PDB ID: 2byp)
[33] has been determined but was not used as a template because
the coordinates of some amino acid atoms are missing. The
secondary structure elements and the location of ImI binding site
in our model are displayed in Figure 2 on the sequence and on the
lowest energy model of a7-nAChR. This model was then
subjected to 10 ns of molecular dynamics simulation. Thirty-four
single point mutations of ImI/a7-nAChR that have been
experimentally described in previous studies [26–30] were then
generated in a series of models extracted over the 10 ns
simulation. Finally, 14 different strategies were compared to
evaluate the mutational energies of single point mutants.
Conformational variability of a7-nAChR in apo state and
bound to ImI
T w os e r i e so f1 0n sm o l e c u l a rd y n a m i c ss i m u l a t i o n so ft h e
a7-nAChR, either in the apo state or bound to ImI, are
Figure 1. Nicotinic acetylcholine receptor structure and a-
conotoxin ImI. (A) Nicotinic acetylcholine receptors (nAChRs) are
ligand gated-ion channels. Their structure is composed of a ligand-
binding domain (red), a transmembrane domain (blue), and an
intracellular domain (white). nAChRs are permeable to Na
+ and K
+
and, for some isoforms, Ca
2+. The opening of the channel is triggered by
acetylcholine or nicotine. One of the acetylcholine binding sites is
indicated as a blue star. (B) a-conotoxin ImI comprises 12 residues and
is C-terminally amidated (indicated by * in the sequence). The structure
features a short a-helix and two disulfide bonds that link cysteines I-III
and II-IV.
doi:10.1371/journal.pcbi.1002011.g001
Author Summary
Conotoxins are peptide toxins extracted from the venom
of carnivorous marine cone snails. Members of the a-
conotoxin subfamily potently block nicotinic acetylcholine
receptors (nAChRs), which are involved in signal transmis-
sion between two neurons or between neurons and
muscle fibers. nAChRs are important pharmacological
targets due to their involvement in the transmission of
pain stimuli and also in numerous neurone diseases and
disorders. Their potency and specificity have led to the
development of a-conotoxins as drug leads, and also to
their use in the investigation of the role of nAChRs in
various physiological processes. The most studied con-
otoxin/nAChR system, ImI/a7, was modeled in this study,
and several computational methods were tested for their
ability to explain the perturbations observed experimen-
tally after introducing single point mutations into either
ImI or the a7 receptor. The aim of this study was to
establish a theoretical basis to rapidly identify new a-
conotoxin mutants that might have improved specificity
and affinity for a given receptor subtype. Furthermore,
hundreds of thousands of conotoxins are predicted to
exist, and computational methods are needed to help
streamline the discovery of their molecular targets.
Conotoxin ImI/a7-nAChR Computational Scanning
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deviation (RMSD) to the initial conformation became stable
after 2000 ps for both simulations, indicating that they had
reached equilibrium (Figure 3A,B). Indeed, the largest fluctu-
ation, which is displayed by the third subunit, is ,1A ˚ over the
last 8000 ps of the simulation. The a-carbon root-mean-square
fluctuations (RMSF) indicate that the b-strand regions are
conformationally stable, but that the C-loop and Cys-loop
regions are flexible (Figure 3C,D). The dynamic property of the
C-loop is particularly interesting, as the change of conforma-
tion of this loop is thought to be vital for the physiological role
of nAChRs [33,37–40]. It has been shown that the interaction
Figure 2. Sequence and structure of a7-nAChR ligand-binding domain. Sequence alignment of Homo sapiens a7-nAChR ligand-binding
domain (LBD) (UniProtKB/SwissProt P36544), Mus musculus a1-nAChR LBD (PDB ID: 1pq1), and Aplysia californica AChBP (PDB ID: 1tg9), which is
structurally analogous to nAChRs. Below the alignment, the secondary structure elements and acetylcholine binding sites are shown on the lowest
energy three-dimensional model of the a7-nAChR nAChR LBD obtained by comparative modeling. Residues in the sequence alignment are
numbered according to the a7-nAChR sequence. The conserved positions between the three sequences are on a dark green background, whereas
the positions presenting amino acids shared by only two sequences are on a light green background. The secondary structure elements are the a-
helix h1 and the b-strands b1-10. The LBD is a pentamer of five subunits. The acetylcholine binding sites, indicated by star symbols, are located at the
interface between the subunits. These binding sites mainly comprise the C-loop from one subunit, which is designated as the principal subunit, and
the beta strands b1, b2, b3, b59 and b6 from another subunit, which is designated as the complementary subunit. The secondary structures of one
subunit are highlighted in the side view, and the arrangement of the subunits and of the binding sites is shown on the top view. In the alignment, the
residues of AChBP in contact with ImI in the crystal structure 2c9t are underlined in blue for positions in the principal subunit and in white for
positions in the complementary subunit.
doi:10.1371/journal.pcbi.1002011.g002
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conformation and this change of conformation has been
hypothesized to trigger the opening of the channel [41].
According to this hypothesis, competitive antagonists stabilize
t h eC - l o o pi na no p e nc o n f o r m a t i o n ,p o t e n t i a l l yp r e v e n t i n gt h e
channel from opening. Interestingly, in our study, the C-loop in
the apo model fluctuates significantly (Figure 3E), whereas the
C-loop of the a7-nAChR in complex with ImI is stabilized in
an open conformation (Figure 3F). It can therefore be
concluded that ImI stabilizes the C-loop in an open
conformation, which, according to previous studies, should
inhibit channel activity.
Molecular dynamics simulation significantly refined the confor-
mation of the a7-nAChR/ImI model. Indeed, after 10 ns
molecular dynamics, the conformation of the C-loop of the a7-
nAChR/ImI model is stable and different from that of the two
templates. As shown in Figure 4, the C-loop of the a7-nAChR/
ImI is more closed than the C-loop of AChBP in complex with ImI
Figure 3. Analysis of the stability of a7-nAChR over 10 ns molecular dynamic simulations in the apo (A,C,E) and ImI-bound (B,D,F)
states. b strand a carbon root-mean-square deviations (RMSD) of each of the subunits over the molecular dynamics simulations to the starting frame
for the apo (A) and ImI-bond models (B). a carbon root-mean-square fluctuation (RMSF) of each subunit of the apo (C) and ImI-bond (D) models.
Fluctuation of the distance between the sulfur atom of a7-C190 side chain and the a carbon of a7-Y32 in the apo (E) and ImI-bond (F) models. This
distance characterizes the closure of the C-loop. The RMSD is calculated using Ca atoms in b strands. The RMSD and distances were averaged using a
16 ps window.
doi:10.1371/journal.pcbi.1002011.g003
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a-bungarotoxin, which is a classical antagonist of nAChR. The
positions of the b-sheets are conserved between the template
AChBP crystal structure and the a7-nAChR/ImI model. The h1
a-helices occupy slightly different positions, with the a7-nAChR a-
helices being closer from the center of the pore than the AChBP
ones (not shown).
Comparison to previous modeling and pairwise
interaction studies
Our model of a7/ImI significantly differs from those [22,32]
that were developed before the publication of the crystallographic
structures of AChBP/ImI [33,34]. In the previous studies, models
were built by homology with crystallographic structures of AChBP
with the C-loop in a closed conformation, but several recent
studies suggest that this C-loop conformation is incompatible with
the nAChR inactive state [38,41]. Moreover, the previous studies
tentatively tried to justify the binding mode of ImI using weak
mutational energy couplings revealed by mutant cycle analyses,
which were interpreted as pairwise interactions [28]. It proved to
be impossible to reproduce all the pairwise interactions identified
by this method [28]. Recently, Gleitsman et al. [42] measured
similar weak mutational energy couplings occurring between
residues located 60 A ˚ from each other, one being in the C-loop of
an nAChR and the other in the middle of the trans-membrane
domain. That study demonstrated that weak couplings are not
evidence of direct interaction. On the contrary, a strong coupling
was observed between a7-Y195 and ImI-R7 [28], and in our
model, the side chains of these two residues are tightly packed
together, as is apparent in Figure 5.
Recently Armishaw et al. [30] docked ImI into a structural
model of the a7-nAChR derived by comparative modeling, using
one of the AChBP/ImI crystallographic structures. Their strategy
involved the mutation of a7-Y93 to Ala before performing the
docking procedure, and finally the ‘‘back’’ mutation of position 93
into Tyr. Presumably, the docking strategy did not succeed to
place the conotoxin without this mutation step. Indeed, docking
molecules onto a structure derived by comparative modeling is a
challenging task because the low accuracy of the receptor
conformation either causes steric hindrance or does not allow
Figure 4. Comparison of the binding site of AChBP/ImI complex (PDB ID: 2c9t), a7-nAChR/ImI complex (model, this work) and a1-
nAChR/bungarotoxin complex (PDB ID: 2qc1). In the a1-nAChR/bungarotoxin structure, only one subunit was crystallized, and the
bungarotoxin is not shown. The model displaying a7-nAChR was obtained by a combination of comparative modeling and molecular dynamics, and
the displayed conformation corresponds to energetically minimized frames after 10 ns of simulations. The C-loop, the principal subunit, and the
complement subunit are indicated. In the three first panels and from left to right, the conformation of the C-loop increasingly reduces the volume of
the binding site. The fourth panel, on the right, shows a superimposition of the AChBP and nAChR subunits, highlighting the different C-loop
conformations between the model and the two experimental templates.
doi:10.1371/journal.pcbi.1002011.g004
Figure 5. Analysis of the binding mode of ImI to the a7-nAChR.
The structure of the binding pocket occupied by ImI after molecular
dynamics simulation is displayed and positions discussed in the text are
highlighted. The a7 principal subunit is in orange, the a7 complemen-
tary subunit is in pale yellow, and ImI is in violet. Nitrogens are in blue,
oxygens are in red and sulfurs are in yellow.
doi:10.1371/journal.pcbi.1002011.g005
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The model presented by Armishaw et al. [31] is very similar to the
final conformation of our molecular dynamics, despite the use of
different strategies. Their model was not compared to previous
experimental mutation studies, but we here provide qualitative
and qualitative explanations to those mutation studies.
Structural explanation of mutational studies
The binding of ImI to the a7-nAChR has been investigated
experimentally and the impact of mutations of a7 and/or ImI on
the affinity (Kd) or inhibition activity (IC50) are known [26–29].
Here we investigate structural explanations for the influence of
single point mutations on a7/ImI affinity through an analysis of
models of the mutated complex. Mutations involving unnatural
residues have not been considered here because their parameters
are less refined than those for standard amino acids. The aim of
our study is to compare different methods to predict the impact of
single point mutations on binding affinities between conotoxin ImI
and a7-nAChR; the use of unnatural residues would complicate
the interpretation of those comparisons as the deviation between
computed and experimental mutational energies could arise from
inaccuracy in the parameters as well as from the methodological
differences. The a7/ImI model will be referred to as the ‘‘wild-
type model’’, whereas the models of the complexes presenting
mutations are referred to as ‘‘mutated models’’. Three positions of
ImI, i.e., D5, P6, and R7, have been found experimentally to be
important for the interaction [26]. Four receptor positions, a7-
N111, a7-Q117, a7-P120 and a7-153, have some influence on the
affinity of the complex but are not directly in contact with ImI in
our model [28].
ImI-D5. The mutation of ImI-D5 to Asn experimentally
decreases the affinity of the complex [27–29]. Residues ImI-D5,
ImI-R7, a7-D197 and a7-P196 are proximate in the wild-type
model, as shown in Figure 6. ImI-D5 is probably involved in
charge and hydrogen bond interactions with ImI-R7, which is in
turn possibly involved in both a charge and hydrogen bond
interactions with the side chain of a7-D197 and the backbone of
a7-P196. In the mutated model ImI-D5N, displayed in Figure 6,
the side chain of ImI-R7 does not contact a7-D197 and a7-P196
as it does in the wild-type model. Presumably, ImI-D5 plays a
significant role to stabilize the conformation of ImI-R7, which
allows ImI-R7 to interact with both a7-D197 and a7-P196. Thus,
the disruption of the interaction between ImI-D5 and ImI-R7,
which is not at the interface, indirectly causes a decrease in affinity
by weakening interface interactions between ImI-R7, a7-P196 and
a7-D197.
ImI-P6. According to our model, ImI-P6 is tightly packed in a
hydrophobic pocket formed by a7-W55, a7-Y93, a7-L119 and
a7-W149 (Figure 5). Mutations of a7-Y93, a7-W149 and to a
lesser extent a7-L119 to a partly hydrophobic Thr residue
decreased ImI affinity, and accordingly, the mutated models
displayed reduced packing around ImI-P6 (not shown). Consistent
with this analysis, an increase in affinity was achieved by
introducing a Pro derivative with increased hydrophobicity [30].
Mutations of ImI-P6 to Gly, Ala or Val reduced the affinity of ImI
for a7 [26,28], which is also consistent with the models. However,
caution should be exercised in the interpretation of those
mutations, as the mutation of P6 induces dramatic
conformational changes of ImI backbone [44]. The method we
used to model the mutated models cannot take into account such
dramatic conformational changes, and therefore the study of ImI-
P6 mutants was not carried out.
ImI-R7. In the wild-type model, the aliphatic part of the ImI-
R7 side chain is in contact with a7-Y93, a7-Y195 and ImI-P196,
whereas the positively charged guanidinium moiety is proximate
to the negatively charged headgroups of a7-D197 and ImI-D5
(Figure 6). Mutation of ImI-R7 to Gln breaks the charge
interactions with a7-D197 and ImI-D5, which is consistent with
the decrease in affinity observed experimentally [28]. Moreover, as
discussed previously, the mutation of ImI-D5 to Asn also
influences the conformation of R7. The mutation of a7-D197 to
Asn decreases the affinity for ImI [28], corresponding to a loss of
charge interaction (not shown).
The involvement of a7-Y195 in van der Waals interactions with
R7 is supported by the observation that a7-Y195T decreases the
binding affinity, whereas a7-Y195F does not [28]. An interaction
between ImI-R7 and a7-Y195 has also been deduced by double
mutant cycle analysis [28].
Mutations of a7-R186 to Ala, Glu, Gln and Val increased the
affinity [28]. In the wild-type model, a charge repulsion interaction
occurs between a7-R186 and ImI-R7 (Figure 6), and this
unfavorable interaction is removed by mutating position 7 into a
non-charged or negatively charged residue.
a7-N111. a7-N111 is the last position of the b59-strand and is
not in direct contact with ImI. The model of the mutant a7-N111S
(Figure 6) features a longer b6 strand and a change in
conformation of the b59-b6 loop compared to the wild-type.
Several side chains located in the binding site, including R79,
Q117 and H115, have a slightly different orientation in the
mutated models. Although our models show that position 111 has
an influence on the binding of ImI, it is difficult to provide simple
qualitative explanations of the increase in affinity measured
experimentally [28].
a7-Q117. Mutation of a7-Q117 to Ala or Ser increases
affinity for ImI [28]. The a7-Q117A model shows that the
conotoxin is closer to the backbone of the b59 and b6-strands
compared to the wild-type (Figure 6) and the buried surface area is
increased by 80 A ˚ 2. This mutation decreases the size of side chain
at position 117 and therefore allows ImI-W10 to have better
packing at the interface. The increased affinity resulting from the
mutation a7-Q117S, which also decreases the size of 117 position
side chain, is explained similarly.
a7-P120. Mutation of a7-P120 to Ala decreases the affinity
[28]. As shown in Figure 6, mutation of a7-P120 to Ala caused a
local conformational change of the backbone, which resulted in
the rearrangement of the neighboring side chain at position 119.
In the wild-type model, the side chain of a7-Ile-119 closely stacks
with ImI-P6, but in the mutated model the side chain of a7-Ile-119
has fewer contacts with ImI. Thus, a7-P120 indirectly contributes
to the affinity by influencing the conformation of a side chain at
the interface.
a7-G153. Mutation of position a7-153 from a Gly to a Ser, a
bulkier residue, results in a drastic decrease in affinity [28]. In the
mutated model the C-loop adopts a more open conformation than
in the wild-type model. It is likely that a steric exclusion between
(7-S153 and (7-P194 forces the C-loop to change its position
relative to the binding site, decreasing the number of interactions
at the interface, and therefore accounting for the drop in affinity
measured experimentally.
Comparison of methods to compute mutational energies
Mutational energies of single point mutants were computed
using two energy functions: molecular mechanics generalized Born
surface area (MM-GB/SA) and molecular mechanics Poisson-
Boltzmann surface area (MM-PB/SA) energy functions. The
mutated models were first refined using either the minimization
based approach (MBA) or the molecular dynamics simulation
based approach (MDBA). For the MBA, mutations were
Conotoxin ImI/a7-nAChR Computational Scanning
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molecular dynamics simulation and the mutated models were
minimized using either explicit water (EWM) or a distance-
dependent dielectric constant (DDDCM). For the MDBA,
mutations were created on the model of the last frame of the
wild-type 10 ns molecular dynamics simulation, and the mutated
models were subjected to 500 ps molecular dynamics. Because the
complex showed only small conformational variations during the
last 8 ns of the simulation, the last frame can be chosen as
representative of the wild-type structure. The energies were
averaged on the minimized mutated models for MBA, and on 50
frames extracted from the last 100 ps of the 500 ps molecular
dynamics for MDBA.
Energy predictions using MBA. The energies of 16 ImI
single point mutants were computed (Table 1) and are compared
with experimental values in Figure 7. Using the simple DDDCM,
MM-GB/SA gave better predictions of mutational energies than
MM-PB/SA, as shown by the correlation coefficient R2 of 0.71
and 0.58 between experimentally derived energies and energies
computed with generalized Born and Poisson-Boltzmann,
Figure 6. Superimposition of wild-type and mutated models. The models of the mutants shown were refined using molecular dynamics and
the conformations shown in this figure are the last frames of the molecular dynamics trajectories. The arrows highlight local conformational changes.
doi:10.1371/journal.pcbi.1002011.g006
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subtle improvement for both energy functions, and MM-GB/SA
still performed better than MM/PB-SA (R
2 of 0.74 and 0.64,
respectively).
It is a priori surprising that the generalized Born method gave
better predictions because generalized Born parameters were
optimized to reproduce the more computationally demanding
results from finite-difference Poisson-Boltzmann [45]. A possible
explanation for this phenomenon is that the approximations
introduced in the generalized Born method are able to partly
ameliorate the inaccuracy of theoretical models, whereas the
Poisson-Boltzmann method cannot. Indeed, it has been shown
that MM-GB/SA provides better ranking of models generated by
docking than MM-PB/SA [46–48]. Few previous studies of
protein/peptide complexes used simultaneously MM-PB/SA and
MM-GB/SA [49] and to our knowledge none made an extensive
comparison of the ability of the two energy functions to rank
mutational energies.
Regarding the refinement method, the small superiority of
EWM over DDDCM mainly arises from the prediction of two
mutational energies, R7E and D5K, which both result in a
reversal of charges. Therefore, models minimized using explicit
water representation seem to be slightly more accurate that the
ones obtained from implicit solvation methods, like DDDCM.
Nevertheless, it should be noted that energy computations using
DDDCM were, on average, four times faster than EWM.
Energy predictions using MDBA. For the MDBA, short
molecular dynamics simulations were carried out to refine the
models of the mutants, and the mutational energies were evaluated
using MM-GB/SA or MM-PB/SA. The resulting energies are
shown in Table 1 and are compared to experimentally derived
energies in Figure 8.
To achieve the simulations within a practical computational
time, only short simulations could be carried out for each mutant.
Because of this short simulation time, the molecular dynamics
trajectories only partially sample the accessible conformational
space. As a result, the conformations of the positions that are not
influenced by the mutations are sampled differently in the
simulation of the wild-type and mutant complexes, and those
differences create artificial noise in the computation of the
mutational energies. To overcome this problem, some atoms were
restrained to their initial location by a quadratic force, and five
strategies were employed to select the atoms that should be
restrained. In strategy (i), all of the receptor atoms located further
than 6 A ˚ from the conotoxin were restrained to their position.
This led to a poor correlation with experimental values, with
R
2=0.16 for MM-GB/SA and R
2=0.40 for MM-PB/SA
(Figure 8). To reduce the possible detrimental influence of
positions located out of the binding site, additional restraints were
added to the system in strategy (ii) by lowering the distance cut-off
to 4.5 A ˚. This change improved the prediction made with MM-
GB/SA (R
2=0.30) but worsened the one computed using MM-
Figure 7. Correlation between experimentally derived and calculated mutational energies of the ImI mutants in the minimization
based approach MBA. Mutational energies were computed using either molecular mechanics generalized Born (GB) surface area (MM-GB/SA) or
molecular mechanics Poisson-Boltzmann (PB) surface area (MM-PB/SA) energy functions at 298 K. The mutated models were refined using MBA with
either distance dependent dielectric constant minimization (DDDCM) or explicit water minimization (EWM). Experimental mutational energies (nnG
Exp) were derived using the corresponding Kd values of ImI wild-type/(7-nAChR and ImI mutants/(7-nAChR [26–28].
doi:10.1371/journal.pcbi.1002011.g007
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2=0.34). The change in cut-off allowed the decrease in
the number of atoms without restraints from about 1000 to 800. In
strategy (iii), the mutated residue was taken as the center of the
distance cut-off. With a 6 A ˚ distance cut-off, only about 400 atoms
were without restraints. The correlation with experimental values
improved for both MM-GB/SA and MM-PB/SA compared to
strategy (ii), with R
2 reaching 0.44 and 0.45, respectively. In
strategy (iv), all the atoms from the receptor were restrained to
their position, but all the atoms from the conotoxin mutants (about
170 atoms) were free to move. Surprisingly, the addition of
restraints on the whole receptor significantly improved the
correlation of both MM-GB/SA and MM-PB/SA, as the R
2
reached 0.70 and 0.59, respectively. In the last strategy (v), all
residues were restrained, which allowed only subtle changes to the
atom positions. The agreement with experimental binding
energies was similar to strategy (iv) as R
2=0.71 for generalized
Born and R
2=0.51 for Poisson-Boltzmann. By only allowing the
atoms to have local moves, the conformational sampling of
strategies (iv) and (v) have similar effect to energy minimization,
and the correlation with experimental energies are closer to the
MBA than strategies (i)-(iii). Nevertheless, despite being consider-
ably more time consuming, the molecular dynamics refinement
approach used in the MDBA did not produce a better prediction
than the minimization approach used in the MBA. We therefore
conclude that the MBA is the best method to use.
Mutational energy of receptor mutants. To further
validate the accuracy of the MBA, 48 additional mutational
energies using DDDCM and EWM were computed by mutating
positions of the receptor (Table 2). The correlation coefficient
between the experimental and predicted mutational energies does
not change significantly by including the predictions made for the
receptor mutants (Figures S2). The stability of the correlation
coefficient upon addition of new data demonstrate that our models
and methods could be used to predict the relative binding affinities
of other single point mutations of the ImI/a7-nAChR system.
Binding energy and mutational energy decompositions
To better understand the energetic components stabilizing the
ImI/a7-nAChR complex, the free energies of the system and the
mutational free energies of the mutated complexes, computed
using EWM, were decomposed into entropic, electrostatic, van der
Waals, and hydrophobic contributions. The solute entropic
contribution to the binding energy has been neglected in our
previous calculations, but it was estimated using normal-mode
analysis in this section. As shown in Table 3, the van der Waals
interactions and the hydrophobic effects stabilize the complex,
whereas the electrostatic contribution is destabilizing. The
observation that the van der Waals interactions and hydrophobic
effect are predominant over the electrostatic interactions correlates
with a statistical analysis of interface features carried out over the
10 ns of the molecular dynamics simulation. During the
simulation, the average buried surface area of the wild-type
complex was of 1150 A ˚ 2, which is twice as large as the average
500 A ˚ 2 of peptide/protein interfaces [50], and can be associated
with the important van der Waals and hydrophobic effect energies.
ImI and a7-nAChR form, on average over the simulation, three
hydrogen bonds and one salt-bridge, and this small number of
electrostatic interactions is consistent with average values for a-
helical peptides [50].
The decomposition of the mutational free energies are displayed
in Table 4 and the correlation between different contributions and
experimentally derived mutational energies are shown in Figure 9.
Figure 8. Correlation between experimentally derived and calculated mutational energies of ImI mutants in the molecular
dynamics based approach MDBA. Mutational energies were computed by using either molecular mechanics generalized Born (GB) surface area
(MM-GB/SA) or molecular mechanics Poisson-Boltzmann (PB) surface area (MM-PB/SA) approaches at 298 K. In the MDBA five alternative position
restraint strategies were employed: (i) all receptor atoms .6A ˚ from the conotoxin were restrained to their position; (ii) all receptor atoms .4.5 A ˚
from the conotoxin were restrained to their position; (iii) all the atoms located .6A ˚ from the mutated residue were restrained to their position; (iv)
all the atoms from the receptor were restrained to their position, and all the atoms from the conotoxin mutants were free to move; and (v) all residues
were restrained to their position. Experimental mutational energies (DDG Exp) were derived using the corresponding Kd values of ImI wild-type/a7-
nAChR and ImI mutants/a7-nAChR [26–28].
doi:10.1371/journal.pcbi.1002011.g008
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PLoS Computational Biology | www.ploscompbiol.org 10 March 2011 | Volume 7 | Issue 3 | e1002011The electrostatic contribution has by far the best agreement with
experimental energies (R
2=0.62 with MM-GB/SA) and is
therefore the major contributor to the specificity between mutants.
The van der Waals interactions also participates, but to a lesser
extent (R
2=0.35). On the contrary, the hydrophobic effect does
not allow differentiation of the mutants (R
2=0.01). With a
correlation coefficient of 0.23, the solute entropy term has only a
small influence on specificity. Furthermore, the correlation
coefficient between the experimentally derived and predicted
mutational energies does not change substantially after including
the solute entropic component (Figure 7 and 9). This justifies the
proposal that solute entropic contributions, which are computa-
tionally demanding, can be neglected when predicting the ranking
of single point mutant binding affinities based on the computation
of binding energies.
Concluding remarks
In this study, an extensive computational analysis of a complex
between an a-conotoxin, ImI, and an nAChR, a7-nAChR, was
carried out. In the absence of the crystal structure of a complete
nAChR extracellular domain, modeling the interaction of an
inhibitor of an nAChR is difficult. Nevertheless, we successfully
studied the binding mode between a-conotoxin ImI and a7-
nAChR using a combination of comparative modeling and
molecular dynamics simulation. Using this model, we have
explained the effect of mutations described in previous experi-
mental studies.
The structures of 16 mutated ImI/a7-nAChR complexes were
refined using MBA or MDBA, and the binding energies were
predicted using MM-PB/SA and MM-GB/SA. To our knowl-
edge, this study constitutes the first attempt to use these energy
functions to study the binding of a range of a-conotoxin variants to
an nAChR. The approach using a simple minimization to refine
the model (MBA) led to the best agreement between predicted
mutational energies and experimental values.
Another important conclusion of our study is that affinity
between ImI analogues and a7-nAChR was mainly governed by
van der Waals and non-polar desolvation energies, whereas the
electrostatic interactions were mainly important for the specificity.
Interestingly, the entropy had little influence on the mutational
energy of single point mutants. Because a-conotoxins share the
same tightly packed structural fold, our observations on the energy
decomposition are likely to help in the rational optimization of a-
conotoxins pharmacological properties in general.
In order to perform extensive computational scanning of a-
conotoxins, a fast and accurate approach is necessary. In this
respect, we have identified that the best method to achieve this
goal is to refine the mutated models by minimization using explicit
solvation and to compute mutational energies using MM-GB/SA.
Materials and Methods
Comparative modeling of a7-nAChR
In the absence of the crystal structure of a7-nAChR, the human
a7-nAChR LBD was modeled using a comparative approach,
following a strategy described previously [51–53]. The crystal
structure of an isolated Mus musculus muscle type extracellular
domain of the a1-nAChR subunit in complex with the inhibitor a-
bungarotoxin was solved at 1.94 A ˚ resolution (PDB ID: 2qc1) [35].
The Mus musculus a1-nAChR subunit shares 38% sequence
identity with the Homo sapiens a7 subunit and superimposes with,
on average, 2.9 A ˚ rmsd with the AChBP subunits. An electron
microscopy structure of a complete muscle type nAChR of Torpedo
marmota (PDB ID: 2bg9) revealed a similar arrangement of subunits
as the one presented by AChBP. As the electron microscopy
structure is of low resolution (4 A ˚), the AChBP structures (PDB ID:
2c9t) were employed as structural templates in our comparative
modeling strategy to orient the five a7 subunits in the pentamer.
The orientations of the side chains were modeled according to the
a1 template (PDB ID: 2qc1) due to its overall higher sequence
identity to the a7 subunit than AChBP. A sequence alignment
between the two structural templates and a7-nAChR LBD is
displayed in Figure 2. The secondary structure elements and
ligand-binding sites observed on the experimental structures and
predicted for a7-nAChR are also shown in Figure 2. The
modeling of the nAChR C-loop required special attention as its
change in conformation allows the binding site to accommodate
ligands of different sizes [33]. In our model, the structure of
AChBP in complex with ImI (PDB ID: 2c9t) was used to derive
restraints in the C-loop region because AChBP has locally higher
sequence identity than a1, and because the C-loop conformation
in the AChBP structure allows ImI to fit in the binding site.
Conversely, the Cys-loop, the b1-b2 loop, the A-loop, and the B-
loop were modeled using information from the a1 template
because it displays higher sequence identity than AChBP. Multiple
sequence alignment between Aplysia californica AChBP and the
LBD of a1, a2, a3, a4, b1, b2, a6, a7, a9 and a10 was generated
using MUSCLE with default parameters [54]. The multiple
alignment between AChBP, a7 and a1 was then manually
adjusted based on structural superimpositions of the crystal
structures of AChBP (PDB ID: 2c9t) and a1 (PDB ID: 2qc1).
The comparative modeling program Modeller [55] (version 9v7)
was then employed to generate 100 three-dimensional structural
models of the a7-nAChR complex. The Cys-loop region was
Table 2. Calculated and experimental mutational energies
(kcal/mol) of the receptor mutants.
DDDCM
a EWM
b
a7 mutant GB
d PB
e GB
d PB
e EXP
c
L92A 0.760.2 0.660.3 160.5 1.260.5 0.460.2
Y93T 6.261.0 3.760.5 6.760.5 6.860.8 2.260.2
S148A 20.260.2 21.660.4 20.860.6 21.360.5 0.560.2
W149T 2.060.4 2.560.7 2.860.6 3.260.7 2.060.2
S150A 0.160.1 20.560.4 20.460.5 0.060.4 0.060.2
R186E 20.360.4 0.160.8 20.260.5 21.060.7 20.860.2
R186Q 20.860.3 21.160.7 0.060.7 0.361.0 20.860.2
R186V 20.560.3 21.660.6 20.760.5 20.560.7 21.260.2
Y188F 20.560.5 20.660.8 20.760.5 20.560.7 0.760.2
Y195D 4.860.28 10.361.0 5.860.6 7.160.6 2.260.2
Y195F 2.260.2 2.460.4 0.660.6 0.060.8 0.060.2
D197N 6.461.0 8.561.8 7.161.0 8.961.5 1.860.2
R
2 0.71 0.58 0.64 0.74
aDistance dependent dielectric constant minimization (DDDCM). The standard
deviations of the mutational energies were computed using 15 frames.
bExplicit water minimization (EWM). The standard deviations of the mutational
energies were computed using 15 frames.
cExperimental mutational energies (EXP) that were derived from experimental
Kd values [26–28] using the equation DDGbinding =E X P=2RT ln[Kd (mutant)/
Kd (wild-type)] at 298 K.
dMutational energy computed using molecular mechanics generalized Born
(GB) surface area (MM-GB/SA) at 298 K.
eMutational energy computed using molecular mechanics Poisson-Boltzmann
(PB) surface area (MM-PB/SA) at 298 K.
doi:10.1371/journal.pcbi.1002011.t002
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and B-loop were modeled based on AChBP. The model selected
according to the DOPE score [56] was analyzed using MolProbity
[57] and 94% residues were in the favorable region of the
Ramachandran plot, which is acceptable for a comparative model
[56].
ImI/a7-nAChR complex
A model of the structure of the complex ImI/a7-nAChR was
obtained by comparative modeling. An X-ray diffraction structure
of the complex between ImI and AChBP (PDB ID: 2c9t) was used
to provide restraints between ImI and the nAChR and also
structural restraints to ImI conformation. The structure of a7-
nAChR was modeled using the same sequence alignment/
structure described previously to model the apo state. The use of
a comparative modeling approach is justified by the fact AChBP
and a7-nAChR are likely to have very similar binding modes
because they share a high level of sequence identity in their
binding sites (52% identity according to alignment in Figure 2).
Molecular dynamics simulation
Molecular dynamics simulations (MD) were performed using
Gromacs 3.3.1 package [55] and the 53a6 forcefield. The ImI/a7-
nAChR model was solvated in a cubic box with an edge length of
11.4 nm solved by adding 40,773 SPC water molecules. 74 Na
+
and 27 Cl
2 ions were added to simulate a physiological NaCl
concentration of 0.1 M and to neutralize the system. The system
was minimized using 1000 steps of steepest descent algorithm. The
temperature was progressively raised from 0 K to 300 K over
100 ps of constant pressure and temperature (NPT) MD
simulation with all the protein atoms restrained to their initial
position. Ten nanosecond NPT MD was then performed on the
whole system without restraints with Berendsen temperature bath
coupling set at 300 K and an isotropic molecule based scaling
setup at 1 atm [58]. The electrostatic interaction between non-
covalent atoms was computed with particle-mesh Ewald method
[59] with a distance cutoff of 10 A ˚. The LINCS algorithm [60]
was used to constrain all bonds and the time step of the simulation
was set to 2 fs. The simulation of the apo state a7-nAChR was
prepared using the same procedure. Ten nanosecond MD
simulations were performed twice for ImI/a7-nAChR and three
times for the a7-nAChR in apo state systems. Stability and
conformational variabilities of those five simulations are provided
in Figure 3 and in supplementary material figure S1.
Models of single point mutants
In the MBA, 15 frames were extracted every 500 ps in the
interval between 3–10 ns of the 10 ns molecular dynamics
simulation trajectory of the wild-type model. Each frame was
minimized using AMBER10 [61] (with the AMBER ff03
forcefield) by 2000 steps of steepest descent algorithm followed
by 2000 steps of conjugate gradient algorithm with the backbone
of the complex restrained. Two thousand five hundred steps of
steepest descent minimization and 2500 steps of conjugate
gradient minimization were then performed without restraints.
The side chains in the ligand were mutated using Modeller and all
the residues (including residues of the ligand) were minimized
using AMBER10 [61]. In the DDDCM approach, e=4r was
used, whereas in the EWM approach, the protein was solvated in a
water box with a minimum of 8 A ˚ between the solute and the side
of the box.
In the MDBA, a water cap with a radius of 16 A ˚ from the
center of the binding pocket was added. MD was only performed
on the mutants of the last frame obtained from MBA above.
Table 4. Decomposition of the mutational energies (kcal/mol) of ImI mutants.
Generalized Born GB Poisson-Boltzmann PB
Mutant vdw
a ent
a ele
a SA
a ele
a SA
a DDG (GB)
b DDG (PB)
c
S4A 0.160.6 4.561.6 20.260.2 0.160.1 0.260.2 0.060.2 4.661.4 4.861.5
D5A 3.260.6 1.961.4 0.660.3 20.160.1 1.760.4 20.260.1 5.661.8 6.562.1
D5K 1.560.8 1.361.0 11.661.6 20.760.2 16.062.2 20.560.2 13.661.6 18.363.3
D5N 1.260.6 0.761.8 2.461.0 20.160.2 1.060.4 20.160.1 4.261.3 2.961.8
R7A 10.960.7 20.661.7 1.860.9 1.360.2 5.161.1 0.960.3 13.461.4 16.362.5
R7E 7.460.9 0.561.7 8.061.8 0.260.1 25.361.6 0.360.1 16.062.0 33.562.9
R7K 3.960.7 2.361.8 7.360.9 0.160.1 9.560.9 0.160.1 13.661.7 15.862.3
R7L 6.360.5 0.862.0 3.760.9 0.760.2 9.760.9 0.660.2 11.461.8 17.262.3
R7Q 5.660.7 2.061.7 2.161.1 0.460.1 7.261.0 0.460.1 10.162.3 15.161.8
A9S 20.760.6 0.861.7 23.561.1 20.360.1 21.860.4 20.160.1 23.761.9 21.961.5
W10A 5.860.5 0.561.8 0.060.5 0.760.2 22.860.3 0.760.2 7.061.7 4.261.1
W10F 1.560.5 1.462.2 1.460.3 0.260.1 0.260.3 0.260.1 4.561.3 3.261.4
W10T 3.560.6 2.462.3 0.960.4 0.460.1 22.260.5 0.460.1 7.362.4 4.262.4
W10Y 1.060.6 3.161.9 21.660.9 20.260.1 22.060.4 0.060.1 2.462.0 2.261.9
R11A 2.260.5 2.661.2 20.460.9 0.460.2 1.461.0 0.360.2 4.761.3 6.561.7
R11Q 1.860.6 2.461.8 1.160.8 0.260.1 1.760.8 0.160.1 5.561.9 6.161.9
aDecomposition of the mutational energy (DDG) into van der Waals (vdw), entropic (ent), electrostatic (ele) and non-polar desolvation (SA) components. Two energy
functions were used: molecular mechanics generalized Born (GB) surface area (MM-GB/SA) and molecular mechanics Poisson-Boltzmann (PB) surface area (MM-PB/SA).
The temperature was set at 298K. The standard deviations of the mutational energies and energy components were computed using 15 frames.
bDDG(GB) is the mutational free energy computed using MM-GB/SA.
cDDG(PB) is the mutational free energy computed using MM-PB/SA.
doi:10.1371/journal.pcbi.1002011.t004
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steps of steepest descent minimization followed by 2000 steps of
conjugate gradient minimization. The water box was equilibrated
by increasing the temperature from 0 to 300 K while maintaining
the solute under constraints, and then further maintaining the
simulation at 300 K for 40 ps. In the production phase, the
restraints in the binding site were removed and 500 ps MD was
performed with a 2 fs time step. The non-bonded cutoff was set to
12 A ˚ and SHAKE was applied for all the bonds involving
hydrogen atoms. For strategy (i), water molecules and residues
within 6 A ˚ of the ligand were flexible; for strategy (ii), water
molecules and residues within 4.5 A ˚ of the ligand were flexible; for
strategy (iii), water molecules and residues within 6 A ˚ of the
mutated residues were flexible; for strategy (iv), all the atoms of the
ligand and water molecules were flexible; and for strategy (v), only
the water molecules were flexible. For every strategy, 50 frames
were extracted every 2 ps in the interval comprised between 400–
500 ps of the 500 ps MD simulation.
Additional MD simulations of some mutants
To provide qualitative explanations to the effect of the
mutations of ImI-D5N, ImI-R7Q, a7-Q117A, a7-R186V, a7-
N111S, a7-S113A, a7-P120A and a7-G153S, additional MD
were performed for at least 500 ps. In those MD, a similar water
cap was used, as described previously, and residues within 6 A ˚ of
the mutated side chain were flexible.
Computation of mutational energy
The values of the binding free energy (DG binding) for each
mutant were calculated based on the following equation:
DGbinding~Gcomplex{Gligand{Greceptor ð1Þ
The free energy can be decomposed into three components:
G~ vGsolutew z vGepolw z vGSAw ð2Þ
where G solute is the solute Gibbs free energy, G epol represents the
polar contribution to the solvation energy and G SA represents
non-polar contribution to the solvation energy. Polar contribution
to the solvation energy is determined by solving the Poisson-
Boltzmann Equation using the PB module implemented in
AMBER10 [61], or the GB approach implemented in AMBER10
[62]. The non-polar contribution to the solvation energy is
calculated using:
GSA~c   SASAza ð3Þ
where solvent-accessible surface area (SASA) was determined
using the Molsurf [63] algorithm with a probe radius of 1.4 A ˚. The
surface tension c and constant parameter a in equation (3) were
taken to their default values 0.0072 kcal/mol
21 A ˚ 2 and, 0 kcal/
mol
21 A ˚ 2 respectively. The effect of residue mutation on the
binding energy was computed using:
DDGbinding~DGbinding mut ðÞ {DGbinding WT ðÞ ð 4Þ
where DDG binding was defined as mutational energy that is the
binding energy difference between the wild-type ligand (DG binding
(WT)) and its mutants (DG binding (mut)).
The entropy contribution was estimated using normal-mode
analysis, which employed the atomic fluctuation matrix produced
from a normal mode calculation [64]. Alternatively, for some
calculations, we made the approximation that the wild-type and
mutated complexes have similar entropies. Using this approxima-
tion:
vGSolutew mut ðÞ {vGSolutew WT ðÞ
~vEMMw mut ðÞ {vEMMw WT ðÞ
ð5Þ
where E MM is the molecular mechanical energies of the proteins
as given by the molecular mechanics potential. This equation was
used to compute the difference of internal Gibbs free energy for
the complex, the ligand and the receptor. The binding free energy
of the mutants was calculated by solving equations (4) and (5) using
the MMPBSA.py script, which is part of the AMBER10
distribution. The Poisson-Boltzmann equations were solved using
Figure 9. Correlation between calculated mutational energy
components of ImI mutants and experimentally derived
mutational energies. The explicit water minimization approach was
employed to compute the Gibbs free energy (DDG) using either
molecular mechanics generalized Born (GB) surface area (MM-GB/SA) or
molecular mechanics Poisson-Boltzmann (PB) surface area (MM-PB/SA)
approaches at 298 K. The energies were decomposed into van der
Waals (vdw), electrostatic (ele), surface area (SA, only shown for GB) and
entropic components (not shown). Experimental mutational energies
(DDG Exp) were derived using the corresponding Kd values of ImI wild-
type/a7-nAChR and ImI mutants/a7-nAChR [26–28].
doi:10.1371/journal.pcbi.1002011.g009
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80.0, respectively, a probe radius of 1.4 A ˚, a grid spacing set to
0.5 A ˚ and ionic strength set to 0.15 M/L. For the GB algorithm,
the salt concentration was set to 0.15 M/L.
Supporting Information
Figure S1 Rmsd, Rmsf and distance plots of the apo-state model
and ImI/a7-nAChR complex over the 10 ns molecular dynamics
simulations. Three a7-nAChR apo-state and two a7-nAChR/ImI
simulations were performed in total. In the first row, b strand a
carbon root-mean-square deviations (RMSD) of each of the
subunits over the molecular dynamics simulations to the starting
frame. In the second row, a carbon root-mean-square fluctuation
(RMSF) of each subunit over the 10 ns molecular dynamics
simulation ensemble. In the third row, fluctuation of the distance
between the sulfur atom of a7-C190 side chain and the a carbon
of a7-Y32. This distance characterizes the closure of the C-loop.
(TIFF)
Figure S2 Correlation between the experimentally derived
mutational energies and calculated mutational energies of ImI
and receptor mutants. Mutational energies were computed using
either molecular mechanics generalized Born (GB) surface area
(MM-GB/SA) or molecular mechanics Poisson-Boltzmann (PB)
surface area (MM-PB/SA) energy functions at 298 K. The
mutated models were refined using MBA with either distance
dependent dielectric constant minimization (DDDCM) or explicit
water minimization (EWM).
(TIFF)
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